Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H25NO3 |
Molecular Weight | 291.3853 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCCC2=O
InChI
InChIKey=IXHBTMCLRNMKHZ-LBPRGKRZSA-N
InChI=1S/C17H25NO3/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3/t12-/m0/s1
Molecular Formula | C17H25NO3 |
Molecular Weight | 291.3853 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:52:15 UTC 2023
by
admin
on
Sat Dec 16 16:52:15 UTC 2023
|
Record UNII |
G6317AOI7K
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175556
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
||
|
WHO-VATC |
QS01ED03
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
||
|
NDF-RT |
N0000000161
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
||
|
NCI_THESAURUS |
C29705
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
||
|
NCI_THESAURUS |
C29576
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
||
|
WHO-ATC |
S01ED03
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4706
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | |||
|
431
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | |||
|
G6317AOI7K
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | |||
|
DB01210
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | |||
|
6438
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | |||
|
DTXSID1043833
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | |||
|
1813
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | RxNorm | ||
|
570
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | |||
|
m6784
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000082825
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | |||
|
CHEMBL1201237
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | |||
|
LEVOBUNOLOL
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | |||
|
SUB08463MIG
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | |||
|
D002040
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | |||
|
C62043
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | |||
|
47141-42-4
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | |||
|
Levobunolol
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | |||
|
39468
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY | |||
|
G6317AOI7K
Created by
admin on Sat Dec 16 16:52:16 UTC 2023 , Edited by admin on Sat Dec 16 16:52:16 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->ANTAGONIST |
Levobunolol (LB) is the levo-rotatory isomer of bunolol, a potent, nonselective antagonist of beta-adrenergic receptors.
|
||
|
TARGET->ANTAGONIST |
Levobunolol (LB) is the levo-rotatory isomer of bunolol, a potent, nonselective antagonist of beta-adrenergic receptors.
|
||
|
SALT/SOLVATE -> PARENT | |||
|
RACEMATE -> ENANTIOMER |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |